Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients-Reference-Cited by-同舟云学术

Utility of a Liquid Formulation of Levo-thyroxine in Differentiated Thyroid Cancer Patients

Published:2014-07-14 Issue:06 Volume:65 Page:332-336
ISSN:2194-9379
Container-title:Drug Research
language:en
Short-container-title:Drug Res (Stuttg)

Author:

Giusti M.¹,Mortara L.¹,Machello N.²,Monti E.¹,Pera G.¹,Marenzana M.²

Affiliation:

1. Endocrine Unit, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

2. Service of Clinical Nutrition, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Publisher

Georg Thieme Verlag KG

Subject

Drug Discovery,General Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0034-1384535.pdf

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review;Endocrine;2024-08-31

2. Efficacy and safety of postoperative levothyroxine sodium tablets for improving serum thyroid hormone levels and tumor marker levels in patients with thyroid tumors;European Journal of Translational Myology;2023-09-05

3. Drug forms of levothyroxine. Is there room for innovation in hypothyroidism treatment?;Clinical and experimental thyroidology;2023-07-14

4. Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial;Endocrine;2022-06-25

5. Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer;Hormones;2022-06-02